6.99
price down icon0.99%   -0.07
pre-market  시장 영업 전:  7.01   0.02   +0.29%
loading
전일 마감가:
$7.06
열려 있는:
$7.06
하루 거래량:
145.98K
Relative Volume:
0.51
시가총액:
$153.28M
수익:
-
순이익/손실:
$-52.07M
주가수익비율:
-33.65
EPS:
-0.2077
순현금흐름:
$-44.93M
1주 성능:
-4.90%
1개월 성능:
-3.05%
6개월 성능:
-32.85%
1년 성능:
-46.84%
1일 변동 폭
Value
$6.91
$7.20
1주일 범위
Value
$6.83
$7.85
52주 변동 폭
Value
$4.81
$14.44

Cybin Inc Stock (CYBN) Company Profile

Name
명칭
Cybin Inc
Name
전화
908 764 8385
Name
주소
100 King Street West, Suite 5600, Toronto
Name
직원
38
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CYBN's Discussions on Twitter

CYBN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CYBN
Cybin Inc
6.99 153.28M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-13 개시 Guggenheim Buy
2021-11-19 다운그레이드 Maxim Group Buy → Hold

Cybin Inc 주식(CYBN)의 최신 뉴스

pulisher
Apr 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Apr 27, 2025
pulisher
Apr 23, 2025

Cybin advances Phase 3 trial for depression treatment By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Announces Additional Strategic Clinical Site Partnerships - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin (CYBN) Expands Strategic Partnerships for Phase 3 MDD Program | CYBN Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin advances Phase 3 trial for depression treatment - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Says Second Phase 3 Study Embrace Expected To Begin Mid-2025 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

CYBNCybin Inc Latest Stock News & Market Updates - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003 - The Joplin Globe

Apr 23, 2025
pulisher
Apr 22, 2025

(CYBN) Trading Report - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 21, 2025

Cybin (CYBN) Partners with Osmind for Psychedelic Therapy Launch - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Psychedelic drug developer Cybin partners with Osmind (CYBN:NYSE) - Seeking Alpha

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - 01net

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners With Osmind to Support Psychiatry Program Pipeline - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs | CYBN Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin's Game-Changing Mental Health Partnership: 800+ Clinics to Deploy Novel Depression and Anxiety Treatments - Stock Titan

Apr 21, 2025
pulisher
Apr 05, 2025

Where are the Opportunities in (CYBN) - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 04, 2025

Filament Health secures investment to remedy concerning financial position - Mugglehead Magazine

Apr 04, 2025
pulisher
Apr 03, 2025

4 Psychedelic Stocks to Buy Now - The Motley Fool

Apr 03, 2025
pulisher
Mar 30, 2025

CYBN Stock Forecast: Projections From 2025 To 2040 - Exla Resources

Mar 30, 2025
pulisher
Mar 28, 2025

Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th - Business Wire

Mar 28, 2025
pulisher
Mar 20, 2025

Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - MSN

Mar 20, 2025
pulisher
Mar 16, 2025

(CYBN) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 12, 2025

Cybin initiated with a Buy at Guggenheim - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks

Mar 11, 2025
pulisher
Mar 07, 2025

Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 04, 2025

Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq

Mar 04, 2025
pulisher
Mar 01, 2025

Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 23, 2025

Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN

Feb 23, 2025
pulisher
Feb 23, 2025

Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

How to Take Advantage of moves in (CYBN) - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 20, 2025

Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor

Feb 20, 2025
pulisher
Feb 18, 2025

Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Cybin stock price target cut to $150 at H.C. Wainwright - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

(CYBN) Investment Analysis - Stock Traders Daily

Feb 12, 2025

Cybin Inc (CYBN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):